Orthopedic Disorder, Shoulder Pain, Surgery, Analgesia
Conditions
Keywords
peng block, suprascapular nerve block, postoperative analgesia
Brief summary
Arthroscopic shoulder surgery, which has been frequently applied in recent years, provides long-term positive clinical results and increases the quality of life after surgery, while it can cause severe pain in the early postoperative period. Postoperative pain management is very important in shoulder arthroplasty. Adequate pain control; mental state, nutrition, cost of care, rehabilitation, and patient satisfaction, are of great importance for the patients' recovery and contribute to a successful surgical outcome. In this study, the investigators aimed to compare the effects of suprascapular nerve block and shoulder pericapsular nerve block, which will be performed preoperatively with ultrasound, on the level of postoperative pain in patients who will undergo shoulder arthroscopy surgery under general anesthesia.
Detailed description
As a result of the power analysis the investigators conducted for this study, the minimum sample size was calculated as 32 people for each group, 64 people in total, at the 90% confidence interval. 64 patients who meet the inclusion criteria will be included in our study. The participants will be randomized and divided into 2 groups. Accordingly, the PENG block will be applied to 32 patients, and the suprascapular block will be applied to 32 patients.
Interventions
The investigators will perform a pericapsular nerve block on that patient group for postoperative analgesia in shoulder arthroscopy.
The investigators will perform a suprascapular nerve block on that patient group for postoperative analgesia in shoulder arthroscopy.
The investigators will perform a pericapsular nerve block on that patient group for postoperative analgesia with bupivacaine hydrochloride
Sponsors
Study design
Eligibility
Inclusion criteria
* Patients who will have shoulder arthroscopy surgery under general anesthesia * Ages of 18-75 * ASA I-III
Exclusion criteria
* Patients with deformity and pathology in the shoulder region * Patients with known local anesthetic allergy * Patients with BMI\>35 * Patients with alcohol and substance addiction * Patients with opioid addiction * Patients who cannot perceive and evaluate pain, such as psychiatric illness, mental retardation
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| The primary outcome measure of the study is the patients' postoperative pain scores (NRS) | 36 hours postoperatively | Numerical rating scale (NRS) at 1, 6, 12, 18, 24, 30, and 36th hours. A numerical rating scale (NRS) requires the patient to rate their pain on a defined scale. For example, 0-10 where 0 is no pain and 10 is the worst pain imaginable. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Postoperative 36-hour total tramadol hydrochloride consumption | 36 hours postoperatively | This will be measured by the PCA device in the 36 hours after |
Countries
Turkey (Türkiye)